Amneal Pharmaceuticals In...

NASDAQ: AMRX · Real-Time Price · USD
9.34
-0.05 (-0.53%)
At close: Aug 15, 2025, 2:17 PM

Amneal Pharmaceuticals Statistics

Share Statistics

Amneal Pharmaceuticals has 313.42M shares outstanding. The number of shares has increased by 50.39% in one year.

313.42M
50.39%
0.01%
43.22%
144.02M
1,974
0.12%

Short Selling Information

The latest short interest is 5.41M, so 1.73% of the outstanding shares have been sold short.

5.41M
1.73%
2.68%
4.06

Valuation Ratios

The PE ratio is -20.94 and the forward PE ratio is 9.48. Amneal Pharmaceuticals's PEG ratio is 1.

-20.94
9.48
0.88
0.9
-22.4
10.06
1
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Amneal Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 1.41, with a Debt / Equity ratio of -23.73.

1.41
0.86
-23.73
5.9
10.66
0.96

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$336.62K
$-14.08K
8,300
0.8
2.9

Taxes

18.86M
-34.29%

Stock Price Statistics

The stock price has increased by 17.37% in the last 52 weeks. The beta is 1.12, so Amneal Pharmaceuticals's price volatility has been higher than the market average.

1.12
17.37%
7.99
8.07
64.3
1,616,912

Income Statement

In the last 12 months, Amneal Pharmaceuticals had revenue of 2.79B and earned -116.89M in profits. Earnings per share was -0.38.

2.79B
1.02B
249.33M
-116.89M
439.77M
203.58M
-0.38
Full Income Statement

Balance Sheet

The company has 110.55M in cash and 2.59B in debt, giving a net cash position of -2.48B.

110.55M
2.59B
-2.48B
-607.06M
3.42B
477.56M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 295.1M and capital expenditures -51.92M, giving a free cash flow of 243.18M.

295.1M
-51.92M
243.18M
0.79
Full Cash Flow Statement

Margins

Gross margin is 36.52%, with operating and profit margins of 8.92% and -4.18%.

36.52%
8.92%
-1.97%
-4.18%
15.74%
8.92%
8.7%

Dividends & Yields

AMRX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AMRX is $11.5, which is 29.9% higher than the current price. The consensus rating is "Buy".

$11.5
29.9%
Buy
4
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

1.79
8